What is Repligen's investing cash flow?

Repligen (RGEN) reported investing cash flow of -$3.99M in Q1 2026.

How has Repligen's investing cash flow changed year-over-year?

Repligen's investing cash flow increased by 94.6% year-over-year, from -$74.11M to -$3.99M.

What is the long-term trend for Repligen's investing cash flow?

Over 4 years (2021 to 2025), Repligen's investing cash flow has grown at a 7.8% compound annual growth rate (CAGR), from -$221.17M to -$298.47M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Repligen RGEN Investing Cash Flow

Investing Cash Flow at other companies

TEC

Bio-TechneTECH

-$5.82M+34.4%

RevvityRVTY

-$78.27M-1,127%

Thermo Fisher ScientificTMO

-$8.96B-1,600%

DanaherDHR

-$249M-2.9%

Agilent TechnologiesA

-$77M+32.5%

Bio-Rad LaboratoriesBIO

-$93.2M-3,314%

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's investing cash flow?: Repligen (RGEN) reported investing cash flow of -$3.99M in Q1 2026.
How has Repligen's investing cash flow changed year-over-year?: Repligen's investing cash flow increased by 94.6% year-over-year, from -$74.11M to -$3.99M.
What is the long-term trend for Repligen's investing cash flow?: Over 4 years (2021 to 2025), Repligen's investing cash flow has grown at a 7.8% compound annual growth rate (CAGR), from -$221.17M to -$298.47M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.